Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Cancer. 2017 May 30;123(19):3791–3798. doi: 10.1002/cncr.30791

Table 1.

Presenting features of patients on AML97 and AML902.

AML97 (n=92) AML02 (n=216) p value

Age (years) 9.0 (0.0 - 20.0) 8.1 (0.0 - 21.0)
Sex
 Male 49% (45) 56% (121) 0.454
 Female 51% (47) 44% (95)
WBC Count
 < 50,000 76% (70) 74% (160) 0.776
 ≥ 50,000 24% (22) 26% (56)
FAB
 M0 2% (2) 1% (2) 0.586
 M1 17% (16) 11% (24) 0.141
 M2 24% (22) 18% (38) 0.211
 M4 21% (19) 25% (55) 0.387
 M5 17% (16) 25% (54) 0.181
 M6 0% (0) 1% (2) 0.999
 M7 14% (13) 12% (25) 0.571
 Unknown 4% (4) 7% (16) 0.45
Initial Risk
 Low 24% (22) 32% (68) 0.218
 Standard 42% (39) 36% (77) 0.304
 High 34% (31) 33% (71) 0.937